In just about two years, Avalon Ventures and GlaxoSmithKline have launched six new biotechs with the promise of four more in the near future. The latest companies to be launched under the collaboration include Adrenergics, CadheRx Therapeutics and Calporta Therapeutics.
Like Sitari Pharmaceuticals, Silarus Therapeutics and Thyritope Biosciences before them, the start-ups are all part of a collaboration established between...